Cardiovascular Systems, Inc. (CSII) Stake Increased by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL lifted its stake in shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) by 96.2% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 81,430 shares of the medical device company’s stock after acquiring an additional 39,930 shares during the quarter. Gamco Investors INC. ET AL owned about 0.25% of Cardiovascular Systems worth $2,292,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UBS Asset Management Americas Inc. boosted its stake in Cardiovascular Systems by 809.3% during the 1st quarter. UBS Asset Management Americas Inc. now owns 8,393 shares of the medical device company’s stock valued at $237,000 after purchasing an additional 7,470 shares during the period. Parametric Portfolio Associates LLC boosted its stake in Cardiovascular Systems by 26.6% during the 1st quarter. Parametric Portfolio Associates LLC now owns 33,672 shares of the medical device company’s stock valued at $952,000 after purchasing an additional 7,072 shares during the period. Alliancebernstein L.P. boosted its stake in Cardiovascular Systems by 51.9% during the 1st quarter. Alliancebernstein L.P. now owns 76,580 shares of the medical device company’s stock valued at $2,165,000 after purchasing an additional 26,160 shares during the period. Teachers Advisors LLC boosted its stake in Cardiovascular Systems by 6.9% during the 1st quarter. Teachers Advisors LLC now owns 102,482 shares of the medical device company’s stock valued at $2,898,000 after purchasing an additional 6,587 shares during the period. Finally, TIAA CREF Investment Management LLC boosted its stake in Cardiovascular Systems by 6.7% during the 1st quarter. TIAA CREF Investment Management LLC now owns 176,711 shares of the medical device company’s stock valued at $4,997,000 after purchasing an additional 11,033 shares during the period. Institutional investors own 72.09% of the company’s stock.

Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) opened at $23.72 on Tuesday. The company has a quick ratio of 3.83, a current ratio of 4.30 and a debt-to-equity ratio of 0.18. Cardiovascular Systems, Inc. has a 52-week low of $23.00 and a 52-week high of $33.11. The company has a market capitalization of $809.70, a P/E ratio of 1,186.50 and a beta of 2.53.

Cardiovascular Systems (NASDAQ:CSII) last issued its earnings results on Wednesday, October 25th. The medical device company reported ($0.06) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.02. Cardiovascular Systems had a positive return on equity of 0.74% and a negative net margin of 0.93%. The business had revenue of $49.70 million during the quarter, compared to analysts’ expectations of $51.00 million. During the same period in the prior year, the firm posted ($0.06) EPS. Cardiovascular Systems’s quarterly revenue was down .2% compared to the same quarter last year. sell-side analysts expect that Cardiovascular Systems, Inc. will post -0.05 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Cardiovascular Systems, Inc. (CSII) Stake Increased by Gamco Investors INC. ET AL” was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this story on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://transcriptdaily.com/2017/11/14/cardiovascular-systems-inc-csii-stake-increased-by-gamco-investors-inc-et-al.html.

Several analysts recently weighed in on CSII shares. Needham & Company LLC restated a “buy” rating and set a $36.00 target price (down previously from $37.00) on shares of Cardiovascular Systems in a research note on Thursday, October 26th. Zacks Investment Research upgraded Cardiovascular Systems from a “sell” rating to a “hold” rating in a research note on Monday. Raymond James Financial, Inc. started coverage on Cardiovascular Systems in a research note on Friday, September 22nd. They set a “market perform” rating for the company. Citigroup Inc. started coverage on Cardiovascular Systems in a research note on Thursday, September 21st. They set a “market perform” rating for the company. Finally, BidaskClub downgraded Cardiovascular Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $35.33.

In related news, CEO Scott R. Ward sold 5,529 shares of the firm’s stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $30.41, for a total transaction of $168,136.89. Following the completion of the sale, the chief executive officer now directly owns 282,536 shares of the company’s stock, valued at approximately $8,591,919.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Edward M. Brown sold 13,031 shares of the firm’s stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $29.09, for a total value of $379,071.79. The disclosure for this sale can be found here. Over the last three months, insiders sold 51,065 shares of company stock valued at $1,514,031. 3.30% of the stock is currently owned by insiders.

Cardiovascular Systems Profile

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Want to see what other hedge funds are holding CSII? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardiovascular Systems, Inc. (NASDAQ:CSII).

Institutional Ownership by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply